sacituzumab govitecan-hziy for injection,
for intravenous use Initial U.S. Approval: 2020
Sacituzumab govitecan-hziy for injection is a “used to treat Urothelial Carcinoma, Breast Cancer“. TRODELVY for injection is a “prescription medicine. It is available in “form and strength” For injection: 180 mg lyophilized powder in single-dose vials for reconstitution.. TRODELVY for injection can be obtained in India upon request.
To inquire about the “offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”
Facts about your medicine
Active substance: sacituzumab govitecan-hziy
Disease Indications-Urothelial Carcinoma, Breast Cancer
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here for TRODELVY usage
(see Drugs@FDA for complete indication)
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
Query For Sacituzumab Govitecan-HZIY for Injection
Know about product usage and updates
sacituzumab govitecan-hziy for injection is a cancer medicine used to treat adults with a type of breast cancer known as triple-negative breast cancer. It is used when it is not possible to remove the cancer with surgery, because the cancer has spread to areas outside the breast (locally advanced) or to other parts of the body (metastatic ). It is used in patients who have had two or more prior systemic (whole body) treatments, including at least one of them for advanced disease.
Who is the supplier of Specialty drug in India?
Indian Pharma Network (IPN) Legitimate consultant and facilitator for Specialty drugs in India. IPN, Delhi can assist you in connecting with prospective distributors, wholesalers, suppliers, and dealers of TRODELVY (sacituzumab govitecan-hziy) for injection IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.
TRODELVY (sacituzumab govitecan-hziy) for injection, for intravenous use Initial U.S. Approval: 2020
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa